Christina K. Olsen
Valby, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Treatment effects on residual cognitive symptoms among partially or fully remitted patients with major depressive disorder: A randomized, double-blinded, exploratory study with vortioxetine.
Journal: Journal of affective disorders
Published: June 27, 2018
Corrigendum to ``The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram'' [Journal of Affective Disorders, 227 (2018) 803-809].
Journal: Journal of affective disorders
Published: May 29, 2018
The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: A short-term, randomized, double-blind, exploratory study.
Journal: Journal of affective disorders
Published: September 25, 2017
The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram.
Journal: Journal of affective disorders
Published: July 05, 2017
The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials.
Journal: The international journal of neuropsychopharmacology
Published: March 23, 2016
Which Cognitive Domains are Improved by Treatment with Vortioxetine?
Journal: The international journal of neuropsychopharmacology
Published: February 23, 2016
A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults.
Journal: The international journal of neuropsychopharmacology
Published: May 03, 2014
Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder.
Journal: International clinical psychopharmacology
Published: November 22, 2013
A schizophrenia rat model induced by early postnatal phencyclidine treatment and characterized by Magnetic Resonance Imaging.
Journal: Behavioural brain research
Published: November 08, 2012
A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder.
Journal: International clinical psychopharmacology
Published: May 11, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026